{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:09:24Z","timestamp":1790118564854,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005635","name":"Funda\u00e7\u00e3o Calouste Gulbenkian","doi-asserted-by":"publisher","award":["SFRH\/BPD\/37880\/2007"],"award-info":[{"award-number":["SFRH\/BPD\/37880\/2007"]}],"id":[{"id":"10.13039\/501100005635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005635","name":"Funda\u00e7\u00e3o Calouste Gulbenkian","doi-asserted-by":"publisher","award":["SFRH\/BD\/48626\/2008"],"award-info":[{"award-number":["SFRH\/BD\/48626\/2008"]}],"id":[{"id":"10.13039\/501100005635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005635","name":"Funda\u00e7\u00e3o Calouste Gulbenkian","doi-asserted-by":"publisher","award":["SFRH\/BD\/65387\/2009"],"award-info":[{"award-number":["SFRH\/BD\/65387\/2009"]}],"id":[{"id":"10.13039\/501100005635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005635","name":"Funda\u00e7\u00e3o Calouste Gulbenkian","doi-asserted-by":"publisher","award":["IF\/01147\/2013"],"award-info":[{"award-number":["IF\/01147\/2013"]}],"id":[{"id":"10.13039\/501100005635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005635","name":"Funda\u00e7\u00e3o Calouste Gulbenkian","doi-asserted-by":"publisher","award":["P-105348\/2009"],"award-info":[{"award-number":["P-105348\/2009"]}],"id":[{"id":"10.13039\/501100005635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/SAU-ENB\/113151\/2009"],"award-info":[{"award-number":["PTDC\/SAU-ENB\/113151\/2009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["FCOMP-01-0124-FEDER-015718"],"award-info":[{"award-number":["FCOMP-01-0124-FEDER-015718"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.nano.2013.12.013","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T03:00:30Z","timestamp":1389150030000},"page":"e1021-e1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Crucial CD8+ T-lymphocyte cytotoxic role in amphotericin B nanospheres efficacy against experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"10","author":[{"given":"Sofia A.","family":"Costa Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Baltazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Jorge","family":"Dinis-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabela","family":"Cordeiro-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2013.12.013_bb0005","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/jps.21179","article-title":"Amphotericin B formulations and drug targeting","volume":"7","author":"Torrado","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2013.12.013_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","article-title":"Amphotericin B","volume":"68","author":"Lemke","year":"2005","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.nano.2013.12.013_bb0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/380971","article-title":"AmB treatment for Indian visceral leishmaniasis: conventional versus lipid formulations","volume":"38","author":"Sundar","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nano.2013.12.013_bb0020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/CMR.9.4.512","article-title":"Carrier effects on biological activity of AmB","volume":"9","author":"Brajtburg","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.nano.2013.12.013_bb0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1371\/journal.pntd.0000818","article-title":"Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent","volume":"4","author":"Meheus","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.nano.2013.12.013_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-409X(01)00104-1","article-title":"Amphotericin B, colloidal dispersion: an improved antifungal therapy","volume":"47","author":"Guo","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2013.12.013_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2008.01979.x","article-title":"Amphotericin B lipid preparations: what are the differences","volume":"14","author":"Adler-Moore","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.nano.2013.12.013_bb0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"Sundar","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2013.12.013_bb0045","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/j.1552-4604.1998.tb04464.x","article-title":"Am Bisome (liposomal amphotericin B): a comparative review","volume":"38","author":"Boswell","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.nano.2013.12.013_bb0050","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2013.12.013_bb0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1461-5347(99)00160-1","article-title":"Lipid-based amphotericin B formulations: from animals to man","volume":"2","author":"Bekersky","year":"1999","journal-title":"Pharm Sci Technol Today"},{"key":"10.1016\/j.nano.2013.12.013_bb0060","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.46.3.828-833.2002","article-title":"Pharmacokinetics, excretion, and mass balanceof liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans","volume":"46","author":"Bekersky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2013.12.013_bb0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1128\/AAC.13.2.271","article-title":"Amphotericin B pharmacokinetics in humans","volume":"13","author":"Atkinson","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2013.12.013_bb0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejps.2009.02.021","article-title":"Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics","volume":"37","author":"Jung","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2013.12.013_bb0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jconrel.2012.05.037","article-title":"PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and Am Bisome","volume":"161","author":"Van de Ven","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2013.12.013_bb0080","doi-asserted-by":"crossref","first-page":"e25744","DOI":"10.1371\/journal.pone.0025744","article-title":"Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome\u00ae or Fungizone\u2122","volume":"6","author":"Italia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2013.12.013_bb0085","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1208\/s12249-012-9876-2","article-title":"Development of amphotericin B-loaded cubosomes through the solemuls technology for enhancing the oral bioavailability","volume":"13","author":"Yang","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.nano.2013.12.013_bb0090","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/mp100267k","article-title":"Amphotericin-B-loaded polymersomes formulation (PAMBO) based on (PEG)3-PLA copolymers: an in vivo evaluation in a murine model","volume":"8","author":"Jain","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2013.12.013_bb0095","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/jac\/dkr002","article-title":"Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes","volume":"66","author":"Prajapati","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2013.12.013_bb0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/nano.2006.1.4.417","article-title":"Optimizing efficacy of amphotericin B through nanomodification","volume":"1","author":"Vyas","year":"2006","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2013.12.013_bb0105","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1166\/jnn.2006.443","article-title":"Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery","volume":"6","author":"Chavanpatil","year":"2006","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.nano.2013.12.013_bb0110","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2013.12.013_bb0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/bmc.947","article-title":"HPLC assay for determination of amphotericin B in biological samples","volume":"22","author":"Espada","year":"2008","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.nano.2013.12.013_bb0120","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2013.12.013_bb0125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0304-4165(70)90096-6","article-title":"Glutathione metabolism of the red cells. Effect of glutathione reductase deficiency on the stimulation of hexose monophosphate shunt under oxidative stress","volume":"215","author":"Paniker","year":"1970","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2013.12.013_bb0130","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1086\/382031","article-title":"Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis","volume":"189","author":"Bousoffara","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2013.12.013_bb0135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.179.4.1367","article-title":"CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major","volume":"179","author":"Wang","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.nano.2013.12.013_bb0140","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2013.12.013_bb0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nano.2013.12.013_bb0150","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","article-title":"The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) devices","volume":"21","author":"Jain","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2013.12.013_bb0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1081\/DDC-100102197","article-title":"Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method","volume":"25","author":"Barichello","year":"1999","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nano.2013.12.013_bb0160","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1016\/j.biomaterials.2011.07.057","article-title":"Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles","volume":"33","author":"Vrignaud","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2013.12.013_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02652049809006840","article-title":"Influence of the stabilizer coating layer on the purification and freeze-drying of poly(d, l-lactic acid) nanoparticles prepared by an emulsion\u2013diffusion technique","volume":"15","author":"Quintanar-Guerrero","year":"1998","journal-title":"J Microencapsul"},{"key":"10.1016\/j.nano.2013.12.013_bb0170","doi-asserted-by":"crossref","first-page":"e913","DOI":"10.1371\/journal.pntd.0000913","article-title":"A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral leishmaniasis in a murine model","volume":"4","author":"Wasan","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.nano.2013.12.013_bb0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/infdis\/jir735","article-title":"An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis","volume":"205","author":"Prajapati","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2013.12.013_bb0180","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/AAC.40.5.1214","article-title":"Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of Am Bisome","volume":"40","author":"Gangneux","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2013.12.013_bb0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2003.08.002","article-title":"Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations","volume":"267","author":"Fukui","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2013.12.013_bb0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/AAC.36.2.299","article-title":"Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs","volume":"36","author":"Fielding","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2013.12.013_bb0195","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1023\/A:1007605024942","article-title":"Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats","volume":"17","author":"Bekersky","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2013.12.013_bb0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/17425255.2012.645536","article-title":"The contribution of oxidative stress to drug-induced organ toxicity and its detection in vitro and in vivo","volume":"8","author":"Pereira","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.nano.2013.12.013_bb0205","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.peptides.2004.06.011","article-title":"Efficacy of human a-casein fragment (54\u201359) and its synthetic analogue compound 89\/215 against Leishmania donovani in hamsters","volume":"25","author":"Sharma","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.nano.2013.12.013_bb0210","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/iai.33.2.498-500.1981","article-title":"Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection","volume":"33","author":"Carvalho","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2013.12.013_bb0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","article-title":"The regulation of immunity to Leishmania major","volume":"13","author":"Reiner","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nano.2013.12.013_bb0220","doi-asserted-by":"crossref","first-page":"e1000431","DOI":"10.1371\/journal.ppat.1000431","article-title":"Stager pp. B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections","volume":"5","author":"Joshi","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nano.2013.12.013_bb0225","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/IAI.74.1.773-776.2006","article-title":"Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen","volume":"74","author":"Polley","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2013.12.013_bb0230","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/adma.201200446","article-title":"Engineering nano- and microparticles to tune immunity","volume":"24","author":"Moon","year":"2012","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2013.12.013_bb0235","doi-asserted-by":"crossref","first-page":"e1002827","DOI":"10.1371\/journal.ppat.1002827","article-title":"IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c(+) cell populations during visceral leishmaniasis","volume":"8","author":"Owens","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nano.2013.12.013_bb0240","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.4049\/jimmunol.181.2.1386","article-title":"Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses","volume":"181","author":"Banerjee","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2013.12.013_bb0245","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1128\/AAC.47.8.2513-2517.2003","article-title":"Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis","volume":"47","author":"Murray","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2013.12.013_bb0250","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.0141-9838.2004.00672.x","article-title":"CD8(+) T cells with parasite-specific cytotoxic activity and aTc1 profile o fcytokine and chemokine secretion develop in experimental visceral leishmaniasis","volume":"25","author":"Tsagozis","year":"2003","journal-title":"Parasite Immunol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:08:26Z","timestamp":1761548906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963414000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1549963414000033"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2013.12.013","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crucial CD8+ T-lymphocyte cytotoxic role in amphotericin B nanospheres efficacy against experimental visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2013.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}